InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Explore the complete record of transactions filed by Jung Melita Sun. Director active across 1 company, notably Terns Pharmaceuticals, Inc.. Cumulatively, 1 disclosures have been logged. Split: 1 buy · 0 sell. Total volume traded: €11k. History available since 30 November 2024. The latest transaction was filed on 30 November 2024 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
1 of 1 declaration